ITCI
Price
$126.89
Change
-$0.30 (-0.24%)
Updated
Jan 14 closing price
Capitalization
6.7B
42 days until earnings call
PBH
Price
$75.78
Change
+$1.15 (+1.54%)
Updated
Jan 14 closing price
Capitalization
3.6B
22 days until earnings call
Ad is loading...

ITCI vs PBH

Header iconITCI vs PBH Comparison
Open Charts ITCI vs PBHBanner chart's image
Intra-Cellular Therapies
Price$126.89
Change-$0.30 (-0.24%)
Volume$16.59M
Capitalization6.7B
Prestige Consumer Healthcare
Price$75.78
Change+$1.15 (+1.54%)
Volume$195.46K
Capitalization3.6B
ITCI vs PBH Comparison Chart
Loading...
ITCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITCI vs. PBH commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCI is a Hold and PBH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (ITCI: $126.89 vs. PBH: $75.78)
Brand notoriety: ITCI: Notable vs. PBH: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ITCI: 926% vs. PBH: 70%
Market capitalization -- ITCI: $6.7B vs. PBH: $3.6B
ITCI [@Pharmaceuticals: Other] is valued at $6.7B. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITCI’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 1 green FA rating(s).

  • ITCI’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 1 green, 4 red.
According to our system of comparison, PBH is a better buy in the long-term than ITCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITCI’s TA Score shows that 3 TA indicator(s) are bullish while PBH’s TA Score has 3 bullish TA indicator(s).

  • ITCI’s TA Score: 3 bullish, 5 bearish.
  • PBH’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than ITCI.

Price Growth

ITCI (@Pharmaceuticals: Other) experienced а +52.46% price change this week, while PBH (@Pharmaceuticals: Other) price change was +2.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.73%. For the same industry, the average monthly price growth was +0.05%, and the average quarterly price growth was -10.55%.

Reported Earning Dates

ITCI is expected to report earnings on May 13, 2025.

PBH is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-3.73% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITCI($6.7B) has a higher market cap than PBH($3.6B). ITCI YTD gains are higher at: 51.928 vs. PBH (-2.958). PBH has higher annual earnings (EBITDA): 10.8M vs. ITCI (-158.85M). ITCI has more cash in the bank: 498M vs. PBH (63.6M). ITCI has less debt than PBH: ITCI (16.9M) vs PBH (1.21B). PBH has higher revenues than ITCI: PBH (1.13B) vs ITCI (462M).
ITCIPBHITCI / PBH
Capitalization6.7B3.6B186%
EBITDA-158.85M10.8M-1,471%
Gain YTD51.928-2.958-1,755%
P/E RatioN/A14.90-
Revenue462M1.13B41%
Total Cash498M63.6M783%
Total Debt16.9M1.21B1%
FUNDAMENTALS RATINGS
ITCI vs PBH: Fundamental Ratings
ITCI
PBH
OUTLOOK RATING
1..100
8158
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
311
SMR RATING
1..100
9261
PRICE GROWTH RATING
1..100
3551
P/E GROWTH RATING
1..100
10037
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ITCI's Valuation (74) in the Biotechnology industry is in the same range as PBH (75) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew similarly to PBH’s over the last 12 months.

ITCI's Profit vs Risk Rating (3) in the Biotechnology industry is in the same range as PBH (11) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew similarly to PBH’s over the last 12 months.

PBH's SMR Rating (61) in the Pharmaceuticals Other industry is in the same range as ITCI (92) in the Biotechnology industry. This means that PBH’s stock grew similarly to ITCI’s over the last 12 months.

ITCI's Price Growth Rating (35) in the Biotechnology industry is in the same range as PBH (51) in the Pharmaceuticals Other industry. This means that ITCI’s stock grew similarly to PBH’s over the last 12 months.

PBH's P/E Growth Rating (37) in the Pharmaceuticals Other industry is somewhat better than the same rating for ITCI (100) in the Biotechnology industry. This means that PBH’s stock grew somewhat faster than ITCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITCIPBH
RSI
ODDS (%)
N/A
Bullish Trend 8 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
72%
N/A
Momentum
ODDS (%)
Bearish Trend 8 days ago
76%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
73%
Bearish Trend 8 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
73%
Bearish Trend 8 days ago
47%
Advances
ODDS (%)
Bullish Trend 14 days ago
74%
Bullish Trend 21 days ago
60%
Declines
ODDS (%)
Bearish Trend 10 days ago
72%
Bearish Trend 9 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
78%
Aroon
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
40%
View a ticker or compare two or three
Ad is loading...
ITCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HCOM14.800.43
+2.96%
Hartford Schroders Commodity Strtgy ETF
STXV29.750.25
+0.85%
Strive 1000 Value ETF
XLSR52.860.21
+0.40%
SPDR® SSGA US Sector Rotation ETF
AMZU41.16-0.28
-0.68%
Direxion Daily AMZN Bull 2X Shares
NVDL63.11-1.41
-2.19%
GraniteShares 2x Long NVDA Daily ETF

ITCI and

Correlation & Price change

A.I.dvisor tells us that ITCI and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITCI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITCI
1D Price
Change %
ITCI100%
-0.24%
ACET - ITCI
32%
Poorly correlated
+3.96%
SXTC - ITCI
30%
Poorly correlated
-4.67%
SUPN - ITCI
25%
Poorly correlated
+0.67%
PRGO - ITCI
24%
Poorly correlated
-3.41%
PBH - ITCI
24%
Poorly correlated
+1.54%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.54%
PAHC - PBH
34%
Loosely correlated
+0.05%
IRWD - PBH
32%
Poorly correlated
-3.18%
SUPN - PBH
28%
Poorly correlated
+0.67%
VTRS - PBH
28%
Poorly correlated
-0.68%
EBS - PBH
26%
Poorly correlated
-0.53%
More